Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0009432 |
Description | A disorder that affects fibroblasts. | Trait category |
Other disease
|
Synonym | fibroblastic disease |
Mapped terms |
3 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001031 (GBE_HC1261) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Fibroblastic disorders (time-to-event) | fibroblastic disorder | 252 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001031/ScoringFiles/PGS001031.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM007918 | PGS001031 (GBE_HC1261) |
PSS004238| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE fibroblastic disorders | — | AUROC: 0.55976 [0.51029, 0.60922] | R²: 0.00596 Incremental AUROC (full-covars): -0.03186 PGS R2 (no covariates): 0.00184 PGS AUROC (no covariates): 0.46286 [0.41124, 0.51449] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007919 | PGS001031 (GBE_HC1261) |
PSS004239| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE fibroblastic disorders | — | AUROC: 0.61535 [0.53232, 0.69839] | R²: 0.02963 Incremental AUROC (full-covars): -0.02095 PGS R2 (no covariates): 0.00331 PGS AUROC (no covariates): 0.4468 [0.36142, 0.53217] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007920 | PGS001031 (GBE_HC1261) |
PSS004240| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE fibroblastic disorders | — | AUROC: 0.60695 [0.58839, 0.62551] | R²: 0.02173 Incremental AUROC (full-covars): 0.01126 PGS R2 (no covariates): 0.00604 PGS AUROC (no covariates): 0.55704 [0.53852, 0.57555] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007921 | PGS001031 (GBE_HC1261) |
PSS004241| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE fibroblastic disorders | — | AUROC: 0.61823 [0.59234, 0.64411] | R²: 0.02603 Incremental AUROC (full-covars): -0.00675 PGS R2 (no covariates): 2e-05 PGS AUROC (no covariates): 0.5053 [0.47836, 0.53224] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM007922 | PGS001031 (GBE_HC1261) |
PSS004242| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: TTE fibroblastic disorders | — | AUROC: 0.61508 [0.60485, 0.62531] | R²: 0.0247 Incremental AUROC (full-covars): 0.02537 PGS R2 (no covariates): 0.01088 PGS AUROC (no covariates): 0.57699 [0.56677, 0.5872] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004238 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004239 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004240 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004241 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004242 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |